$9.740
-0.365 (-3.75%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GLUE por análisis de gráficos similares
Alphio's GLUE stock price prediction model matches the current Monte Rosa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.81 (+0.75%). The 1-week path is $10.20 (+4.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Monte Rosa Therapeutics Inc?
Monte Rosa Therapeutics Inc (GLUE) is currently not a strong buy due to its recent price decline and negative sentiment, despite a current price of $9.74 and a forward P/E of 10.02. The RSI is at 29.94, indicating it is oversold, but the stock has seen a 36.38% decline year-to-date, suggesting caution. The main risk is the insider selling activity, which increased by 122.61% over the last month, indicating potential lack of confidence from insiders.
GLUE cerró en $9.74 el Friday, tras bajar -3.75%
Monte Rosa Therapeutics Inc (GLUE) last closed at $9.74, losing -3.75%. These facts feed the 1-day and 1-week GLUE price prediction above.
Factores de la previsión
Los factores de la previsión de Monte Rosa Therapeutics Inc (GLUE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GLUE, ordenadas por similitud.
Análisis de estacionalidad de GLUE
Historically the probability of a positive October return for GLUE is 46.55%. November offers the highest probability of a positive month at 100.00%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de GLUE
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $2.74 | $6.63 | $7.74 | -31.91% |
| Nov 2026 | $8.46 | $10.53 | $12.50 | +8.09% |
| Dec 2026 | $7.18 | $10.32 | $14.75 | +5.96% |
En 2026, se proyecta que Monte Rosa Therapeutics Inc (GLUE) oscile entre $2.74 y $14.75.
Previsión mensual de Monte Rosa Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Monte Rosa Therapeutics Inc promedie $6.63, con un mínimo de $2.74 y un máximo de $7.74.
En Nov de 2026, se proyecta que Monte Rosa Therapeutics Inc promedie $10.53, con un mínimo de $8.46 y un máximo de $12.50.
En Dec de 2026, se proyecta que Monte Rosa Therapeutics Inc promedie $10.32, con un mínimo de $7.18 y un máximo de $14.75.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.